Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://kalefhki085632.wikiinside.com/4503127/this_new_drug_retatrutide_australia_a_potential_solution_for_losing_weight